NCT02611219

Brief Summary

The purpose of this feasibility study is to test the potential for successful implementation of an intervention designed to study the effect of six hours out of bed time on the overall level of deconditioning in pediatric stem cell transplant (SCT) patients. Previous research has demonstrated that deconditioning occurs rapidly over the course of the hospitalization post-transplant and can negatively impact quality of life. By encouraging patients to be out of bed for six hours each day, it is anticipated that patients will experience less deconditioning than those patients who previously had no established minimum time out of the bed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Mar 2015

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

May 27, 2016

Status Verified

May 1, 2016

Enrollment Period

1.1 years

First QC Date

November 12, 2015

Last Update Submit

May 26, 2016

Conditions

Outcome Measures

Primary Outcomes (4)

  • Recruitment and retention of participants throughout the study

    -Analyze the number of participants enrolled who continue through the 6 week clinic visit

    Baseline through 6 week clinic visit (up to an estimated 82 days)

  • Number of participants who achieve 6 hours out of bed through the 6 week clinic visit

    Baseline through 6 week clinic visit (up to an estimated 82 days)

  • Quality of life as measured by General Health Module questionnaires

    Discharge from hospital (estimated to be 40 days)

  • Quality of life as measured by General Health Module questionnaires

    Baseline through 6 week clinic visit (up to an estimated 82 days)

Study Arms (2)

Arm 1: Pediatric patients

EXPERIMENTAL

* Patients will wear a Fitbit Flex during hospitalization * Completion of Demographic Data Form at baseline, discharge from hospital, and at the six week clinic visit * Assist in recording time out of bed using the SCT Daily Activity Log * Fill out (some with help of parents) applicable questionnaires: Child Health Ratings Inventories-General Health Module (5-12 years), General Health Module-Baseline Adolescent-Self Report (13-18 years), General Health Module-Follow Up Adolescent-Self Report (13-18 years) at baseline, discharge from hospital, and at six week clinic visit * Patients will be assessed using standard physical therapy assessment tools to determine functioning, muscle strength, endurance, and mobility: The Functional Independence Measure for Children and Manual Muscle Testing is done weekly, discharge from hospital, and at six week clinic visit. The 3-Minute Step Test is done at admission, discharge from hospital, and at six week clinic visit.

Other: General Health Module-Baseline Adolescent-Self Report (13-18 years)Other: General Health Module-Follow Up Adolescent-Self Report (13-18 years)Other: Demographic Data FormOther: SCT Daily Activity LogOther: The Functional Independence Measure for ChildrenOther: Manual Muscle TestingOther: 3-Minute Step TestOther: HSCT Module-Follow Up Adolescent-Self Report (13-18 years)Other: HSCT Module-Follow Child-Self Report (5-12 years)

Arm 2: Parents of pediatric patients

EXPERIMENTAL

* Parents will be considered participants as they will be completing study questionnaires. * Completion of Demographic Data Form at baseline * Assist in recording time out of bed using the SCT Daily Activity Log * Fill out applicable questionnaires: General Health Module-Baseline Parent Report -Adolescent (13-18 Years), General Health Module-Follow Up Parent Report-Adolescent (13-18 years), General Health Module-Baseline Parent Report-School Age (5-12 years), and General Health Module Follow Up Parent Report-School Age (5-12 years), HSCT Module-Follow UP Parent Report School Age (5-12 years), HSCT Module-Follow Up Parent Report Adolescent (13-18 years), HSCT Module-Follow Up Adolescent-Self Report (13-18 years), HSCT Module-Follow Child-Self Report (5-12 years) at baseline, discharge from hospital, and at six week clinic visit. * Assist child with Child Health Ratings Inventories-General Health Module (5-12 years) at baseline, discharge at hospital, and at six week clinic visit

Other: General Health Module-Baseline Parent Report-Adolescent (13-18 years)Other: General Health Module-Follow Up Parent Report-Adolescent (13-18 years)Other: General Health Module-Baseline Parent Report-School Age (5-12 years)Other: General Health Module-Follow Up Parent Report-School Age (5-12 years)Other: Demographic Data FormOther: SCT Daily Activity LogOther: HSCT Module-Follow Up Parent Report-adolescent (13-18 years)Other: HSCT Module-Follow Up Parent Report-School Age (5-12 years)

Interventions

* 38 question questionnaire * Answers range from 1=all of the time to 5=none of the time

Arm 1: Pediatric patients

* 38 question questionnaire about child * Answers range from 1=all of the time to 5=none of the time

Arm 1: Pediatric patients

* 38 question questionnaire about child * 49 question questionnaire about parent * Answers range from 1-all of the time to 5=none of the time

Arm 2: Parents of pediatric patients

* 38 question questionnaire about child * 49 question questionnaire about parent * Answers range from 1-all of the time to 5=none of the time

Arm 2: Parents of pediatric patients

* 34 question questionnaire about child * 49 question questionnaire about parent * Answers range from 1-all of the time to 5=none of the time

Arm 2: Parents of pediatric patients

* 34 question questionnaire about child * 49 question questionnaire about parent * Answers range from 1-all of the time to 5=none of the time

Arm 2: Parents of pediatric patients

-16 questions about demographics such as household income, race, and gender

Arm 1: Pediatric patientsArm 2: Parents of pediatric patients

* Uses Fitbit Flex * Log that lists time in 15 minute increments and allows for checking when out of bed and describing the activity that occurred while out of bed

Arm 1: Pediatric patientsArm 2: Parents of pediatric patients

* 18-item, 7-level ordinal scale instrument that measures a child's consistent performance in essential daily functional skills. Three main domains (selfcare, mobility, and cognition) are assessed by interviewing or by observing a child's performance of a task to criterion standards * Categorized into 2 main functional streams: "Dependent" (ie, requires helper: scores 1-5) and "Independent" (ie, requires no helper: scores 6-7). Scores 1 (total assistance) and 2 (maximal assistance) belongs to the "Complete Dependence" category. Scores 3 (moderate assistance), 4 (minimal contact assistance), and 5 (supervision or set-up) belongs to the "Modified Dependence" category. Scores 6 (modified independence) and 7 (complete independence) belongs to the "Independent" category.

Also known as: WeeFIM
Arm 1: Pediatric patients

-Isometric muscle strength is tested in specific positions, usually with the muscle at an optimal working length. Using a "break" test, the test giver overpowers the muscle being tested to determine the muscle grade.

Also known as: MMT
Arm 1: Pediatric patients

* Using an aerobic step, the participant walks up and down for a given amount of time with the heart rate being checked before and after * Using the difference in heart rate and a shortness of breath scale, this test is able to give an estimate of aerobic tolerance

Arm 1: Pediatric patients

* 7 question questionnaire about child * Answers range from 1=all of the time to 5=none of the time

Arm 1: Pediatric patients

* 10 question questionnaire about child * Answers range from 1=all of the time to 5=none of the time

Arm 1: Pediatric patients

* 7 question questionnaire about child * 49 question questionnaire about parent * Answers range from 1=all of the time to 5=none of the time

Arm 2: Parents of pediatric patients

* 7 question questionnaire about child * 49 question questionnaire about parent * Answers range from 1=all of the time to 5=none of the time

Arm 2: Parents of pediatric patients

Eligibility Criteria

Age7 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Ages 7-17 years
  • Admitted to hospital for stem cell transplant
  • Speaks English
  • Parents of children ages 7-17 years
  • Parents of children admitted to hospital for stem cell transplant
  • Speaks English

You may not qualify if:

  • Parents of children admitted to transplant unit for autologous stem cell transplant, donor lymphocyte infusions, mesenchymal cell infusions, a second stem cell transplant, graft versus host disease or other complications post stem cell transplant will not be included

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

MeSH Terms

Interventions

2-methylcyclopentadienyl manganese tricarbonylExercise Test

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Heather Taylor, RN, BSN, CPHON

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2015

First Posted

November 20, 2015

Study Start

March 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

May 27, 2016

Record last verified: 2016-05

Locations